No content results match your keyword.
Content
You have successfully logged out.
Not registered yet?
Friday, 13 November 2026
B. Braun ensures high security standards throughout the product life cycle by using globally accepted standards. We have established processes to monitor the latest vulnerabilities, threats, or risks and will proactively implement measures as required.
Successful exploitation of these vulnerabilities requires specific prerequisites and could allow a sophisticated attacker to compromise the security of the Space communication devices, allowing an attacker to escalate privileges, view sensitive information, upload arbitrary files, and perform remote code execution.
Under very specific conditions, successful exploitation of these vulnerabilities could allow an attacker to modify the configuration of a connected infusion pump Perfusor®, Infusomat®, Infusomat® P from the Space product family while the pump is not delivering therapy.
These conditions include the following: (i) the attacker has already gained access to this specific hospital network, (ii) the affected pumps are connected to a hospital network, (iii) the attacker specifically targets the affected device using the identified vulnerabilities, (iv) the infusion pump is not delivering a therapy (it is “Turned Off” or in “Standby Mode”).
These vulnerabilities do not allow an attacker to modify a therapy while the infusion pump is actively delivering therapy!
B. Braun has received no reports of exploitation or incidents associated with these vulnerabilities in real-world use environment. B. Braun has already addressed the identified vulnerabilities through software updates and recommends customers to update affected devices in their market.
The following versions of B. Braun products are affected:
Installations of Space infusion pumps without the above listed communication devices are not affected.
B. Braun An Out-Of-Bounds Write due to missing input validation is possible in the autoprogramming interface of SpaceCom and Space Battery pack with WiFi which could lead to a denial of service of the affected communication device.
CVE-2026-97357 has been assigned to this vulnerability. A CVSS v3.1 base score of 6.5 has been assigned, the CVSS vector string is (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L). The CVSS 4.0 base score is 6.9 (CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N).
An inclusion of web functionality from an untrusted source could allow remote code execution on SpaceCom.
CVE-2026-97358 has been assigned to this vulnerability. A CVSS v3.1 base score of 5.8 has been assigned, the CVSS vector string is (CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:C/C:L/I:L/A:L). The CVSS 4.0 base score is 7.0 (CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:L/VI:L/VA:L/SC:L/SI:H/SA:L).
There exists an improper privilege management vulnerability that could cause privilege escalation at the SpaceCom and Space Battery pack SP with WiFi.
CVE-2026-97361 has been assigned to this vulnerability. A CVSS v3.1 base score of 7.8 has been assigned, the CVSS vector string is (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H). The CVSS corresponding 4.0 base score is 8.5 (CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N).
CRITICAL INFRASTRUCTURE SECTORS: Healthcare and Public Health
COUNTRIES/AREAS DEPLOYED: Worldwide
COMPANY HEADQUARTERS LOCATION: Germany
Fabian Weber and Dr. Florian Hauser with CODE WHITE GmbH reported these vulnerabilities to B. Braun.
The following versions include a patch for this vulnerability:
Contact your B. Braun representative or technical service for support with the update!
As a general security measure, B. Braun recommends applying established network security practices appropriate to the healthcare facility’s network architecture and risk assessment. These include network segmentation and access controls that limit device access to authorized systems and users. The affected communication devices should not be directly accessible from the internet or untrusted networks.
Wireless networks should use appropriate industry-standard encryption and authentication. Additional controls such as firewalls, VLANs, network monitoring, and intrusion detection or prevention may be applied where appropriate.
These measures reduce network exposure and complement, but do not replace applicable software updates and product-specific remediation measures.
Please contact our global security team at productsecurity@bbraun.com if you have any further questions, require detailed technical information, or have any other support issue concerning the security of our products and services.
If you are a B. Braun customer and need support, please contact your local B. Braun representative.
This is the global B. Braun vulnerability disclosure. Customers in the United States and customers in Canada using the software ‘U’ should refer to the U.S.-specific vulnerability disclosure available at www.bbraunusa.com/productsecurity.
Your feedback matters! Participate in our customer survey to help us enhance our website, products and services. Thank you for your support!